Umme Habiba Sumaya

Umme Habiba Sumaya

Auto-generated profile, based on publicly available information

Umme Habiba Sumaya

Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj 8100, Bangladesh

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Phytochemical Insights
Verified
Journal Article
Open access
PDF file
IRImam Hossen Rakib
Imam Hossen Rakib
RHRakib Hossan
Rakib Hossan
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
NYNoshin Tasnim Yana
Noshin Tasnim Yana
FSFowjia Ahmed Safa
Fowjia Ahmed Safa
USUmme Habiba Sumaya
Umme Habiba Sumaya
Scutellarein (STN), a bioactive flavone found in various medicinal plants such as Scutellaria baicalensis and Scutellaria lateriflora. It has a variety of pharmacological actions, including anticancer properties. This study explores STN’s anticancer activity against various cancer cell lines. A literature review was conducted using databases such as PubMed, ScienceDirect, and Google Scholar, focusing on research evaluating STN’s anticancer efficacy. The results showed that STN has significant anticancer properties against various types of cancer, such as blood, colon, colorectal, gastric, liver, lung, ovarian, and renal cancers. STN reduces cell growth by cell cycle arrest, triggers apoptosis through caspase activation, and inhibits metastasis by suppressing mitochondrial membrane potential (MMP) and epithelial mesenchymal transition (EMT) markers. It modulates important pathways such as ERK, Wnt/β-catenin, and PI3K/Akt/NF-κB. Together, these systems prevent the growth and metastasis of cancer cells. The compound has exhibited prominent cytotoxicity in diverse cancer cell lines.

27 March 2025 in Journal of Chemistry Insights and Discoveries
Verified
Journal Article
Open access
PDF file
IRImam Hossen Rakib
Imam Hossen Rakib
AHArif Hossain
Arif Hossain
USUmme Habiba Sumaya
Umme Habiba Sumaya
NSNasimul Haque Shipon
Nasimul Haque Shipon
NSNazmus Sakib
Nazmus Sakib
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
Cancer is a severe disease caused by genetic variations leading to uncontrolled cell proliferation and metastasis. Xanthotoxol (XTL), a bioactive furocoumarin from Fructus Cnidii and Cnidium monnieri, exhibits various pharmacological activities, including anticancer effects. However, its anticancer potential has not yet been specifically reviewed. This study explores its effects on various cancer cell lines through a literature review using PubMed, and Google Scholar. Findings reveal that XTL has significant anticancer activity against lung, skin, blood, and thyroid cancers. It induces apoptosis by activating pro-apoptotic factors like caspase 3, 7, 8, 9, and Bax while inhibiting proliferation, colony formation, DNA replication, migration, and invasion. Our study also showed that it exhibited good pharmacokinetic properties and reduced toxicity. However, most studies are limited to in vitro experiments, lacking in vivo and clinical evaluations. Further research is needed to validate its safety, bioavailability, and therapeutic efficacy in cancer treatment.

24 September 2025 in Journal of Chemistry Insights and Discoveries
Verified
Journal Article
Open access
PDF file
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
IHImran Hossain
Imran Hossain
RHRakib Hossan
Rakib Hossan
HBHasna Banu
Hasna Banu
KAKhadija Akter
Khadija Akter
USUmme Habiba Sumaya
Umme Habiba Sumaya
Genistein (GT), a soy-derived isoflavone, have received attention due to their possible anticancer effects. The present research is designed to explore the anticancer potential of GT in the therapeutic management of breast cancer (BC) with molecular mechanisms. For this, data have been collected from plausible different online databases, including PubMed, Web of Science, Google Scholar, PubChem, ScienceDirect, Scopus, Springer Link, and Wiley Online. The findings highlight GT’s potential to reduce oxidative damage, induce apoptosis, and modulate the cell lifecycle in BC cells. It inhibits cancer cell proliferation by affecting the human epidermal growth factor receptor 2 (HER2), phosphoinositide 3-kinase/ protein kinase B (PI3K/AKT), and hedgehog regulatory pathways. Moreover, GT exhibits promising pharmacokinetic properties, including high intestinal absorption (95.5%) and strong Caco-2 permeability, with metabolism primarily via CYP1A2 and CYP2C19. However, its poor blood-brain barrier (BBB) permeability and low water solubility present difficulties to the systemic bioavailability. Toxicological investigations demonstrate a dose-dependent effect of GT, with large dosages causing toxicity and low concentrations showing therapeutic potential. Clinical studies emphasize its complex involvement in BC, with differing findings on benefits and risks, indicating the need for additional safety and efficacy study.

11 August 2025 in Journal of Phytochemical Insights
Verified
Journal Article
Open access
PDF file
MIMizan
Mizan
SMShawon Miah
Shawon Miah
USUmme Habiba Sumaya
Umme Habiba Sumaya
NYNoshin Tasnim Yana
Noshin Tasnim Yana
MKMst Muslima Khatun
Mst Muslima Khatun
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
Discovery of the genus Tarenna campaniflora and its traditional uses was obtained by living in forest or semi-forest areas and by close observations of the indigenous populations. This study evaluated the phytochemical constituents, antioxidant potential, antimicrobial efficacy, and thrombolytic activity of ethanolic leaf extract of Tarenna campaniflora. Qualitative phytochemical screening revealed the presence of various bioactive metabolites. DPPH assay demonstrated notable antioxidant activity (IC50 = 0.877 µg/mL), comparable to ascorbic acid (IC50 = 0.839 µg/mL). Disc diffusion assay showed antimicrobial activity, with the highest inhibition against Escherichia coli (18 mm). The extract also exhibited clot lysis (22.42%), compared to streptokinase (31.17%). The findings support the therapeutic potential of T. campaniflora, warranting further pharmacological investigations.

17 August 2026 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
Md. Sakib Al HasanMd. Sakib Al Hasan
Md. Sakib Al Hasan
NSNaznin Shahria
Naznin Shahria
YEYasin Emon
Yasin Emon
MAMohammad alshahrani
Mohammad alshahrani
EMEmon Mia
Emon Mia
MIMd. Torequl Islam
Md. Torequl Islam
Background: Neurological disorders are a major global health challenge in the current era, and they need new therapeutic treatments. Aims: This review evaluates the neurobiological activity of Paeonol (PNL) focusing on its antioxidant, anti‐inflammatory, and cognitive enhancing effects in various neurodegenerative disorders. Methods: A literature search (up to March 2025) was conducted via PubMed, ScienceDirect, Scopus, and other databases using MeSH terms related to PNL's pharmacology and neuroprotection. Inclusion criteria encompassed preclinical studies (in vitro and in vivo) and clinical trials, while exclusion criteria eliminated non‐English papers and non‐neurodegenerative research. Results: PNL, a bioactive phenolic compound from Paeonia suffruticosa , has shown antioxidative, anti‐inflammatory, and neuroprotective effects. PNL reduces oxidative stress by boosting the activity of superoxide dismutase (SOD) and glutathione (GSH) while decreasing reactive oxygen species (ROS) and lipid peroxidation. It also reduces neuroinflammation by inhibiting key pathways such as nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), toll‐like receptor 4 (TLR4), and mitogen‐activated protein kinase (MAPK), and it affects apoptosis‐related proteins like B‐cell lymphoma 2 (Bcl‐2) and Bcl‐2‐associated X protein (Bax). In Alzheimer's disease (AD) models, PNL reduces amyloid‐β plaques and some pro‐inflammatory cytokines like interleukin‐1 beta (IL‐1β) and tumor necrosis factor‐alpha (TNF‐α), improving cognitive function. For ischemic stroke, it reduces infarction volume and microglial activation by targeting TLR2/4 and NF‐κB. PNL has anticonvulsant effects in epilepsy and protects dopaminergic neurons in Parkinson's disease (PD). It also demonstrates anxiolytic and antidepressant properties by modulating Brain‐Derived Neurotrophic Factor (BDNF), Nerve Growth Factor (NGF), and oxidative stress markers. PNL is quickly absorbed with moderate bioavailability and low blood–brain barrier permeability. It effectively treats unstable angina but is less effective for osteoarthritis pain. Though safe at therapeutic doses, high concentrations can be cytotoxic. Conclusion: Further clinical research is needed to confirm its neurotherapeutic potential.